Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * |
Title | Target CML | CML in later |
Description | By later lines, Chronic Myeloid Leukemia (CML) stops being the “good cancer.” Learn about CML in later lines and where there are unmet |
Keywords | N/A |
WebSite | targetcml.com |
Host IP | 217.114.85.100 |
Location | Sweden |
Site | Rank |
US$380,173
Last updated: 2023-05-17 05:25:57
targetcml.com has Semrush global rank of 27,840,773. targetcml.com has an estimated worth of US$ 380,173, based on its estimated Ads revenue. targetcml.com receives approximately 43,867 unique visitors each day. Its web server is located in Sweden, with IP address 217.114.85.100. According to SiteAdvisor, targetcml.com is safe to visit. |
Purchase/Sale Value | US$380,173 |
Daily Ads Revenue | US$351 |
Monthly Ads Revenue | US$10,528 |
Yearly Ads Revenue | US$126,335 |
Daily Unique Visitors | 2,925 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
targetcml.com. | A | 7198 | IP: 217.114.85.100 |
targetcml.com. | NS | 1800 | NS Record: a7-64.akam.net. |
targetcml.com. | NS | 1800 | NS Record: dns2.novartis.com. |
targetcml.com. | NS | 1800 | NS Record: a24-65.akam.net. |
targetcml.com. | NS | 1800 | NS Record: a2-66.akam.net. |
targetcml.com. | NS | 1800 | NS Record: dns4.novartis.com. |
targetcml.com. | NS | 1800 | NS Record: a28-67.akam.net. |
targetcml.com. | NS | 1800 | NS Record: a1-254.akam.net. |
targetcml.com. | NS | 1800 | NS Record: dns1.novartis.com. |
targetcml.com. | NS | 1800 | NS Record: a9-65.akam.net. |
targetcml.com. | NS | 1800 | NS Record: dns3.novartis.com. |
Content intended for health care professionals. Target CML Unmet Needs in CML Expert Perspectives in CML Unmet Needs in CML Expert Perspectives in CML Unmet Needs in CML Expert Perspectives MENU --> --> --> --> BY LATER LINES, CML STOPS BEINGTHE “Good Cancer” 1-6 Find out how Later lines of CML may be associated with increased intolerance and resistance. 1,6 After multiple lines of ATP-competitive TKIs, patients may face intolerance challenges. 7-11 Even low-grade, chronic TKI intolerance can impact compliance with therapy, which in turn can lead to poor outcomes. 12,13 Resistance challenges also can become more common with later lines of ATP-competitive TKIs and using line after line of these therapies may lead to increased failure rates. 2,14,15 What experts from around the world say... “…when a patient has already resistance to a second-generation tyrosine kinase inhibitor, what do you do next? …it is a complicated scenario, and it is one that emphasizes the need for |
HTTP/1.0 301 Moved Permanently Location: https://www.targetcml.com/ Server: BigIP Connection: Keep-Alive Content-Length: 0 HTTP/2 200 date: Tue, 08 Mar 2022 08:37:01 GMT content-type: text/html; charset=utf-8 cache-control: private vary: Accept-Encoding set-cookie: ASP.NET_SessionId=tlv3bpx3hlcur4hys0c3okam; path=/; secure; HttpOnly; SameSite=Lax set-cookie: ASP.NET_SessionId=tlv3bpx3hlcur4hys0c3okam; path=/; secure; HttpOnly; SameSite=Lax set-cookie: __RequestVerificationToken=DA1Ca33OrU0EH_l9jqTaVjMCKfmeVDmxnhH1k-e45bga3NM_MJCPAtXb8CVL3Px3rFD5IaYfmw7qLWsWdEV_8igP5cwDyKkUFjjtzF9vSJs1; path=/; secure; HttpOnly content-security-policy: default-src 'self' 'unsafe-inline' 'unsafe-eval' fonts.googleapis.com fonts.gstatic.com www.googletagmanager.com www.google-analytics.com unpkg.com *.msecnd.net api.fouanalytics.com *.episerver.net *.doubleclick.net *.b2c.com:444 *.b2c.com dc.services.visualstudio.com www.google.com insight.adsrvr.org *.kaltura.com *.googleapis.com maps.gstatic.com *.typekit.net analytics.google.com cdn.cookielaw.org geolocation.onetrust.com data: blob: bat.bing.com request-context: appId=cid-v1:fbded6d8-2f5c-4cb0-adf7-2ae9d814644f access-control-expose-headers: Request-Context x-xss-protection: 1; mode=block x-content-type-options: nosniff strict-transport-security: max-age=31536000; includeSubDomains x-frame-options: SAMEORIGIN set-cookie: ARRAffinity=a3d188e4c5edb839386a7b88827706ea0075d1d071bff061af873d6196dbbe34;Path=/;HttpOnly;Secure;Domain=www.targetcml.com set-cookie: ARRAffinitySameSite=a3d188e4c5edb839386a7b88827706ea0075d1d071bff061af873d6196dbbe34;Path=/;HttpOnly;SameSite=None;Secure;Domain=www.targetcml.com cf-cache-status: DYNAMIC expect-ct: max-age=604800, report-uri="https://report-uri.cloudflare.com/cdn-cgi/beacon/expect-ct" server: cloudflare cf-ray: 6e8a3f19b8759d45-DME |
Domain Name: TARGETCML.COM Registry Domain ID: 2550761798_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.markmonitor.com Registrar URL: http://www.markmonitor.com Updated Date: 2020-12-08T23:20:25Z Creation Date: 2020-08-04T14:29:02Z Registry Expiry Date: 2022-08-04T14:29:02Z Registrar: MarkMonitor Inc. Registrar IANA ID: 292 Registrar Abuse Contact Email: abusecomplaints@markmonitor.com Registrar Abuse Contact Phone: +1.2083895740 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: A1-254.AKAM.NET Name Server: A2-66.AKAM.NET Name Server: A24-65.AKAM.NET Name Server: A28-67.AKAM.NET Name Server: A7-64.AKAM.NET Name Server: A9-65.AKAM.NET Name Server: DNS1.NOVARTIS.COM Name Server: DNS2.NOVARTIS.COM Name Server: DNS3.NOVARTIS.COM Name Server: DNS4.NOVARTIS.COM DNSSEC: unsigned >>> Last update of whois database: 2022-03-08T09:39:59Z <<< |